Rigel Pharmaceuticals, Inc. (RIGL)
42.17
-0.16
(-0.38%)
USD |
NASDAQ |
Dec 10, 13:32
Rigel Pharmaceuticals Total Assets (Quarterly): 242.53M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Catalyst Pharmaceuticals, Inc. | 1.052B |
| Amicus Therapeutics, Inc. | 868.81M |
| Perspective Therapeutics, Inc. | 294.82M |
| Nektar Therapeutics | 301.35M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.92M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.5176 |
| Current Ratio | 2.277 |
| Net Debt Paydown Yield | -0.02% |